Mortality outcomes in individuals with MASLD versus MASLD and increased alcohol intake
Journal of Gastroenterology and Hepatology · 2024
DOI: 10.1111/jgh.16726 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Majd B Aboona und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Alcohol Drinking. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Background and Aim Metabolic dysfunction‐associated steatotic liver disease (MASLD) has become a leading cause of chronic liver disease worldwide. A new entity termed MetALD has also been described and is defined as individuals with MASLD and increased alcohol intake. However, the natural history of MetALD compared with MASLD is unknown. We aimed to compare longitudinal outcomes in patients with MASLD versus MetALD.
Methods
This study was performed using data from the National Health and Nutrition Examination Survey from 2011 to 2018. MASLD patients (defined by the United States Fatty Liver Index > 30) who met cardiometabolic criteria including body mass index (BMI) > 25 (BMI > 23 in Asians), hypertension, diabetes mellitus, dyslipidemia, and hypertriglyceridemia were included. MetALD was defined as MASLD with increased alcohol intake (3–6 standard drinks per day in males; 2–5 standard drinks per day in females). A comparison of overall, cardiovascular, cancer‐related, and other causes of mortality in patients with MASLD versus MetALD was performed.
Results
A total of 2838 individuals with MASLD and 2557 individuals with MetALD were included with a median follow‐up time of 56 months. MetALD patients were at increased risk of cancer‐related mortality compared with patients with MASLD (hazard ratio 1.32; 95% confidence interval 1.14–1.53; P < 0.01). However, there was no significant difference in overall, cardiovascular, and other causes of mortality.
Conclusions
Patients with MetALD were at higher risk for cancer‐related mortality than MASLD. Close attention to regular cancer surveillance and accurate classification of alcohol consumption in individuals with diagnosed MASLD is warranted to help improve patient care and outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA.
- Immunology Unit, Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.
- Division of Clinical Data Analytics and Decision Support, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA.
- Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA.
ORCID-Profile: Majd B Aboona, Pojsakorn Danpanichkul, Karn Wijarnpreecha
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Aboona, M. B., Danpanichkul, P., Chen, V. L., Rangan, P., Kim, D., Alkhouri, N., Fallon, M. B., Noureddin, M., Arab, J. P., & Wijarnpreecha, K. (2024). Mortality outcomes in individuals with MASLD versus MASLD and increased alcohol intake. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16726
Vancouver
Aboona MB, Danpanichkul P, Chen VL, Rangan P, Kim D, Alkhouri N, et al. Mortality outcomes in individuals with MASLD versus MASLD and increased alcohol intake. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16726
BibTeX
@article{Aboona2024,
author = {Aboona, Majd B and Danpanichkul, Pojsakorn and Chen, Vincent L and Rangan, Pooja and Kim, Donghee and Alkhouri, Naim and Fallon, Michael B and Noureddin, Mazen and Arab, Juan Pablo and Wijarnpreecha, Karn},
title = {Mortality outcomes in individuals with MASLD versus MASLD and increased alcohol intake},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
doi = {10.1111/jgh.16726}
}
EUVIMED